美股市場個股詳情
AMRN 阿瑪琳
- 0.549
- +0.024+4.52%
收盤價 11/22 16:00 (美東)
- 0.550
- +0.002+0.27%
盤後 19:07 (美東)
2.26億總市值-5486市盈率TTM
0.560最高價0.521最低價137.28萬股成交量0.530今開0.525昨收74.89萬成交額0.36%換手率虧損市盈率(靜)4.11億總股本1.37052周最高0.42市淨率2.10億流通值0.45752周最低--股息TTM3.84億流通股675.000歷史最高--股息率TTM7.53%振幅0.457歷史最低0.545平均價1股每手
關於阿瑪琳公司
阿瑪琳股份有限公司 是一家生物製藥公司，專注於商業化和開發治療藥物以改善心血管(CV)健康並降低心血管(CV)風險。其商業化產品包括Vascepa。
公司介紹
公司代碼AMRN
公司名稱阿瑪琳
上市日期1993/04/01
發行價格6.00
成立日期1989
CEOMr. Aaron D. Berg
所屬市場納斯達克
員工數量275
證券類型存託憑證
ADS轉換比例1.0 : 1.0
年結日12-31
公司地址Iconic Offices, The Greenway,Block C Ardilaun Court, 112–114,St. Stephens Green
城市Dublin
省份都柏林
國家愛爾蘭共和國
郵編2
電話353-1-6699-020
董事高管
- 姓名
- 職務
- 年薪
- Aaron D. Berg
- Director, President and Chief Executive Officer
- 244.81萬
- Dr. Steven B. Ketchum, PhD
- Executive Vice President, President, Research and Development and Chief Scientific Officer
- 235.06萬
- Jonathan N. Provoost
- Executive Vice President, Chief Legal and Compliance Officer and Secretary
- 65.93萬
- Thomas C. Reilly
- Executive Vice President, Head of Global HR and Finance, Chief Financial Officer and Principal Accounting Officer
- 220.20萬
- Peter Fishman
- Vice President and Global Controller
- --
- Dr. Odysseas D. Kostas, M.D.
- Chairman of the Board
- 65.04萬
- Patrice Bonfiglio
- Independent Director
- 62.69萬
- Mark DiPaolo, Esq.
- Independent Director
- 62.10萬
- Louis Sterling, III
- Independent Director
- 62.94萬
- Keith L. Horn
- Independent Director
- 63.21萬
- Diane E. Sullivan
- Independent Director
- 63.08萬
- Dr. Paul Cohen, M.D.
- Independent Director
- 62.21萬
- Oliver O'Connor
- Independent Director
- 61.18萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據